Literature DB >> 14430381

A clinical and biochemical study of a trial of iproniazid in the treatment of depression.

C M PARE, M SANDLER.   

Abstract

Entities:  

Keywords:  DEPRESSION/therapy; IPRONIAZID/therapy

Mesh：

Substances：

Year:  1959        PMID： 14430381      PMCID： PMC497384          DOI： 10.1136/jnnp.22.3.247

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  19 in total

1.  Acute hepatic necrosis following iproniazid therapy; value of glutamic-oxaloacetic transaminase estimation in early detection.

Authors:  C M PARE; M SANDLER
Journal:  Lancet       Date:  1959-02-07       Impact factor: 79.321

2.  Release of serotonin from blood platelets by reserpine in vitro.

Authors:  A CARLSSON; P A SHORE; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1957-07       Impact factor: 4.030

3.  A preliminary report on marsilid.

Authors:  F J AYD
Journal:  Am J Psychiatry       Date:  1957-11       Impact factor: 18.112

4.  [Not Available].

Authors:  G DESHAIES; N RICHARDEAU; F DECHOSAL
Journal:  Ann Med Psychol (Paris)       Date:  1957-03       Impact factor: 0.380

5.  Paper chromatography of urinary indoles.

Authors:  J B JEPSON
Journal:  Lancet       Date:  1955-11-12       Impact factor: 79.321

6.  Evidence that serotonin has a role in brain function.

Authors:  B B BRODIE; A PLETSCHER; P A SHORE
Journal:  Science       Date:  1955-11-18       Impact factor: 47.728

7.  Indications for use of iproniazid in psychiatric practice.

Authors:  P J DALLY
Journal:  Br Med J       Date:  1958-06-07

8.  Therapeutic trial of iproniazid (marsilid) in depressed and apathetic patients.

Authors:  R L DEVERTEUIL; H E LEHMANN
Journal:  Can Med Assoc J       Date:  1958-01-15       Impact factor: 8.262

9.  Increase of 5-hydroxytryptamine in blood platelets by isopropyl-isonicotinic acid hydrazide.

Authors:  A PLETSCHER; A BERNSTEIN
Journal:  Nature       Date:  1958-04-19       Impact factor: 49.962

10.  Endogenous creatinine in serum and urine.

Authors:  R S HARE
Journal:  Proc Soc Exp Biol Med       Date:  1950-05
View more
  15 in total

1.  Merton Sandler (March 1926-August 2014).

Authors:  Irwin Kopin; Rita Kopin
Journal:  J Neural Transm (Vienna)       Date:  2015-02       Impact factor: 3.575

2.  Hormonal and behavioral effects associated with intravenous L-tryptophan administration.

Authors:  A Winokur; N D Lindberg; I Lucki; J Phillips; J D Amsterdam
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Serotonin transporter protein in autopsied brain of chronic users of cocaine.

Authors:  Junchao Tong; Jeffrey H Meyer; Isabelle Boileau; Lee-Cyn Ang; Paul J Fletcher; Yoshiaki Furukawa; Stephen J Kish
Journal:  Psychopharmacology (Berl)       Date:  2020-06-03       Impact factor: 4.530

Review 4.  Review of the pharmacology of existing antidepressants.

Authors:  P S Spencer
Journal:  Br J Clin Pharmacol       Date:  1977       Impact factor: 4.335

Review 5.  Dopamine and disease.

Authors:  A Barbeau
Journal:  Can Med Assoc J       Date:  1970-10-17       Impact factor: 8.262

6.  Amines and abnormal mood.

Authors:  W G Dewhurst
Journal:  Proc R Soc Med       Date:  1969-11

Review 7.  Physiological and pathological changes in tissue monoamine oxidase activity.

Authors:  M B Youdim; M Holzbauer
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

8.  Monoamine oxidase inhibitors in depression.

Authors:  P Rowan
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-15

9.  Selective inhibition of MAO-A but not MAO-B activity increases rat pineal melatonin.

Authors:  G F Oxenkrug; R McCauley; I M McIntyre; C Filipowicz
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

10.  Tryptophan metabolism in depression.

Authors:  G Curzon; P K Bridges
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-10       Impact factor: 10.154
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.